Skip to main content

Month: February 2020

IBA – Transparency Notification

Louvain-la-Neuve, Belgium, February 18, 2020, 17.30Summary of the notificationIBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 17, 2020.In its notification, Norges Bank has notified, that following an acquisition of IBA shares with voting rights and a disposal of equivalent financial instruments, its total holding in IBA SA remains the same as in its previous notification but its holding in voting rights has crossed upwards the 3% threshold on February 14, 2020.In details, on February 14, 2020, Norges Bank owned (A) 961.258 IBA shares with voting rights...

Continue reading

IBA – PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE

Louvain-la-Neuve, Belgique, 18 Février 2020, 17.30Résumé de la notificationIBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir effectuer une notification en matière de transparence conformément à l’article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes (« loi transparence »), suite à une notification reçue le 17 février 2020.Dans sa notification, Norges Bank annonce que, suite à une acquisition d’actions IBA avec droit de vote et une cession d’instruments financiers assimilés, sa participation totale dans IBA SA est restée la même que lors de sa déclaration précédente mais que sa participation en actions avec droits de vote a franchi à la hause le seuil de 3% le 14 février 2020.En détail, au 14 février...

Continue reading

Invesco Ltd.: Form 8.3 – NMC Health PLC

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.             KEY INFORMATION2.             POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)   Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Innovation Pharmaceuticals Exploring Lead Defensin Mimetic Drug Candidate Brilacidin as Potential Novel Coronavirus Treatment

“Defensins are conceptually ideal for defense against different viral infections”WAKEFIELD, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announced today the Company is exploring its lead defensin mimetic drug candidate, Brilacidin, as a potential novel coronavirus treatment.Over the last few weeks, the Company has received inquiries asking about Brilacidin’s potential to treat the Coronavirus given the urgent worldwide need to find effective treatments for this deadly epidemic.Coronavirus (now being referred to as “COVID-19”) continues to represent a significant life-threatening risk in China and throughout the world, with currently over 71,000 diagnosed cases across 29 countries, resulting in nearly 1,800 reported deaths. The containment...

Continue reading

Update on 2020 Drilling at the Philadelphia High-Grade Gold-Silver Vein Property

Mohave County, Arizona*Visible Gold in 5 out of 9 holes*VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) — Arizona Silver Exploration Inc. (the “Company” or “Arizona Silver”) (TSX-V: AZS) (OTCQB: AZASF) is pleased to announce that it has completed the initial 9 holes of the Q1 2020 drilling program at the 100% owned Philadelphia high-grade gold-silver vein property.Q1 2020 Drilling ProgramThe Company completed an initial 9-hole RC drilling program to test the along-strike and down-dip extensions of the high-grade gold and silver vein target located in Mohave County, northwestern Arizona. High-grade in the Philadelphia vein was identified by core drilling at the property in October 2019 which intersected high grade in the last hole of the 2019 program, PC19-2T (Press Release dated November 13, 2019), and which...

Continue reading

FRO – Invitation to Q4 2019 Results Conference Call and Webcast

Frontline Ltd.’s preliminary fourth quarter 2019 results will be released on Thursday February 27 2020, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontline.bm ahead of the conference call.In order to attend the conference call you may do one of the following:a. WebcastGo to the Investor Relations section at www.frontline.bm and follow the “Webcast” link.b. Conference CallParticipant dial-in telephone numbers:Participants will be asked for their full name & Conference ID.A Q&A session will be held after the teleconference/webcast. Information on how to submit questions will be given at the beginning of the session.The presentation material which will be used in the teleconference/webcast...

Continue reading

TFI International annonce la clôture de son appel public à l’épargne d’une valeur de 230 millions de dollars américains

MONTRÉAL, 18 févr. 2020 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE et TSX : TFII), un chef de file nord-américain de l’industrie du transport et de la logistique, a annoncé aujourd’hui la clôture de son placement négocié précédemment annoncé d’actions ordinaires aux États-Unis et au Canada, qui constitue le premier appel public à l’épargne de TFI International aux États-Unis. TFI International a émis un total de 6 900 000 actions, dont 900 000 actions par suite de l’exercice intégral par les preneurs fermes de leur option de surallocation. Les actions ont été émises à un prix unitaire de 33,35 $ US, soit l’équivalent de 44,20 $ CA l’action, selon le taux de change de la Banque du Canada au moment de l’établissement du prix, pour un produit brut de 230 115 000 $ US à TFI International (environ 305 millions $ CA).TFI International...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.